Epstein—Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed—Sternberg cells
Kikkeri N. Naresh(University of Washington), Kishor Bhatia(International Network for Cancer Treatment and Research), M.A. Muckaden(Homi Bhabha National Institute), C.S. Soman(Tata Memorial Hospital), Vijaya Srinivas(Tata Memorial Hospital), T Saikia(Tata Memorial Hospital), R. Badwe(Dana-Farber Cancer Institute), J. Johnson(National Cancer Institute), Ian Magrath(Uniformed Services University of the Health Sciences), K.A. Dinshaw(Tata Memorial Hospital), Suresh H. Advani(Jaslok Hospital)
Cited by 76
Related Papers
Paediatric cancer in low-income and middle-income countries
|The Lancet Oncology|2013|432
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023
|Annals of Oncology|2023|218
Consolidation Radiation After Complete Remission in Hodgkin's Disease Following Six Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Chemotherapy: Is There a Need?
|Journal of Clinical Oncology|2003|202
Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.
|PubMed|1995|110
Inhibition of Phosphatidylinositol 3′-Kinase/AKT Signaling Promotes Apoptosis of Primary Effusion Lymphoma Cells
|Clinical Cancer Research|2005|109